查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1265978

單細胞基因序列的全球市場

Single-Cell Genome Sequencing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 89 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

單細胞基因序列的全球市場在2030年前將達到64億美元

在COVID-19後改變的商務環境中，2022年26億美元的單細胞基因序列的全球市場，在2030年前將達到64億美元的規模，在2022年～2030年預計將以年複合成長率12％增長。本報告所分析之市場區隔之一的儀器年複合成長率將記錄12.8％，到分析期間結束時將達到41億美元。預計考慮疫情後的復甦，試劑領域今後8年的年複合成長率將修正為10.7％。

美國市場估算為7億5,800萬美元，中國則將以年複合成長率11.2％增長

美國的單細胞基因序列市場在2022年估算為7億5,800萬美元。作為世界第2大經濟大國的中國，在2022年～2030年年複合成長率預計將為11.2％，在2030年前將達到11億美元的市場規模。其他熱門的地區市場有日本和加拿大，從2022年到2030年將各以10％和9.2％的速度成長。在歐洲市場中，德國以年複合成長率6.8％成長。

調查對像企業範例

  • 10x Genomics
  • Agilent Technologies, Inc.
  • BGI
  • Bio-Rad Laboratories
  • DNA Electronics Ltd.
  • F Hoffmann-La Roche Ltd.
  • Fluidigm
  • Illumina, Inc.
  • Johnson & Johnson
  • Novogene
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • QIAGEN
  • Thermo Fisher Scientific, Inc.
  • Zephyrus Biosciences Inc.

目錄

第1章 調查手法

第2章 摘要整理

  • 市場概要
  • 主要企業
  • 市場趨勢與推動因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 全球其他地區

第4章 競爭

簡介目錄
Product Code: MCP22773

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Single-Cell Genome Sequencing Market to Reach $6.4 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Single-Cell Genome Sequencing estimated at US$2.6 Billion in the year 2022, is projected to reach a revised size of US$6.4 Billion by 2030, growing at aCAGR of 12% over the period 2022-2030. Instruments, one of the segments analyzed in the report, is projected to record 12.8% CAGR and reach US$4.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Reagents segment is readjusted to a revised 10.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $758 Million, While China is Forecast to Grow at 11.2% CAGR

The Single-Cell Genome Sequencing market in the U.S. is estimated at US$758 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 11.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10% and 9.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.8% CAGR.

Select Competitors (Total 33 Featured) -

  • 10x Genomics
  • Agilent Technologies, Inc.
  • BGI
  • Bio-Rad Laboratories
  • DNA Electronics Ltd.
  • F Hoffmann-La Roche Ltd.
  • Fluidigm
  • Illumina, Inc.
  • Johnson & Johnson
  • Novogene
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • QIAGEN
  • Thermo Fisher Scientific, Inc.
  • Zephyrus Biosciences Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Single-Cell Genome Sequencing - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Single-Cell Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Single-Cell Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Academic & Research Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Academic & Research Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Academic & Research Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Biotech & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Biotech & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Biotech & Biopharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for NGS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for NGS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 24: World 16-Year Perspective for NGS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 26: World Historic Review for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 27: World 16-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for qPCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 29: World Historic Review for qPCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 30: World 16-Year Perspective for qPCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Microarray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Microarray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 33: World 16-Year Perspective for Microarray by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for MDA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 35: World Historic Review for MDA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 36: World 16-Year Perspective for MDA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 37: World Single-Cell Genome Sequencing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Single-Cell Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2014, 2023 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2014, 2023 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2014, 2023 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2014, 2023 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2014, 2023 & 2030
  • JAPAN
    • Single-Cell Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2014, 2023 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2014, 2023 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2014, 2023 & 2030
  • CHINA
    • Single-Cell Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 67: China 16-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2014, 2023 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 70: China 16-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2014, 2023 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 73: China 16-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2014, 2023 & 2030
  • EUROPE
    • Single-Cell Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Single-Cell Genome Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Single-Cell Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2014, 2023 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2014, 2023 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2014, 2023 & 2030
  • FRANCE
    • Single-Cell Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 88: France 16-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2014, 2023 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 91: France 16-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2014, 2023 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 94: France 16-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2014, 2023 & 2030
  • GERMANY
    • Single-Cell Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2014, 2023 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2014, 2023 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2014, 2023 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2014, 2023 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Single-Cell Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2014, 2023 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2014, 2023 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2014, 2023 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2014, 2023 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Single-Cell Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2014, 2023 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2014, 2023 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2014, 2023 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2014, 2023 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 148: Rest of World 16-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2014, 2023 & 2030

IV. COMPETITION